Clinical Trial Update: Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial results assess the efficacy and safety of MT-5547 in patients with osteoarthritis of the knee or hip and moderate to severe pain. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• MT-5547 (MT-5547)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Osteoarthritis, Knee / Osteoarthritis, Hip | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-05-17